SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2018 / Cilt: 45 - Sayı: 3

Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in patients with psoriasis vulgaris

Psöriazis vulgaris hastalarında nötrofil/lenfosit oranı, trombosit/lenfosit oranı, ortalama trombosit hacmi ve C-reaktif protein değerleri

İsa AN
DERYA UÇMAK
Pages
327–334
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MPV can be a better marker of inflammation compared to PLR and NLR since it was significantly higher in the patients with psoriasis vulgaris compared to the healthy subjects and also correlated with the PASI score

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Recent reports indicate that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), and C-reactive protein (CRP) are key markers of systemic inflammation.
📊
Key Findings & Data:These markers have also been shown to be significantly increased in patients with psoriasis vulgaris compared to control subjects.
💡
Conclusion & Impact:MPV can be a better marker of inflammation compared to PLR and NLR since it was significantly higher in the patients with psoriasis vulgaris compared to the healthy subjects and also correlated with the PASI score
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Recent reports indicate that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), and C-reactive protein (CRP) are key markers of systemic inflammation. These markers have also been shown to be significantly increased in patients with psoriasis vulgaris compared to control subjects. In this study, we aimed to evaluate the relationship between serum levels of NLR, PLR, MPV, and CRP and nail involvement, presence of arthritis, duration of disease, and Psoriasis Area and Severity Index (PASI) scores in patients with psoriasis vulgaris. Methods: The study included 133 patients with psoriasis vulgaris that had no systemic, infectious, or autoimmune diseases and a control group of 107 healthy volunteers. The patients were divided into two groups based on their PASI scores: (I) mild (PASI 0.05). Similarly, no significant relationship was found between the NLR and PLR values and PASI score, presence of arthritis, nail involvement, and duration of disease (p>0.05). Conclusion: NLR and CRP can be useful markers of inflammation in patients with psoriasis vulgaris; however, the absence of a correlation between NLR and the severity of disease may lead to a limitation in the clinical use of NLR. MPV can be a better marker of inflammation compared to PLR and NLR since it was significantly higher in the patients with psoriasis vulgaris compared to the healthy subjects and also correlated with the PASI score

Özet

Amaç: Son yıllarda nötrofil/lenfosit oranı (NLO), trombosit/lenfosit oranı (TLO),ortalama trombosit hacmi(OTH) ve C reaktif protein(CRP)’nin sistemik inflamasyonun önemli göstergeleri olduğu gösterilmiştir. Yapılan çalışmalarda psöriazis vulgaris hastalarında NLO, TLO, OTH ve CRP ’nin kontrol gurubuna göre daha yüksek olduğu gösterilmiştir. Çalışmamızda psöriazisli hastaların NLO, TLO, OTH ve CRP düzeyleri ölçüldü ve bu parametrelerin tırnak tutulumu, artrit varlığı, hastalık süresi ve PAŞİ skoru ile ilişkili olup olmadığı araştırıldı. Yöntemler: Herhangi bir sistemik hastalığı, infeksiyöz hastalığı ve otoimmun hastalığı olmayan 133 psöriazis vulgaris hastası ve 107 sağlıklı kontrol çalışmaya dahil edildi. Hastalar PAŞİ skoruna göre hafif (PAŞİ 0.05) NLO ve TLO değerleri ile PAŞİ skoru, artrit varlığı, tırnak tutulumu ve hastalık süresi arasında istatistiksel olarak anlamlı bir ilişki saptanmadı. (p>0.05) Sonuç: NLO ve CRP’ nin psöriazis hastalarında inflamasyonu göstermede uygun bir parametre olduğu söylenebilir bununla birlikte NLO’ nun hastalık şiddetiyle korele olmaması klinik kullanımını kısıtlayabilir. OTH’ nın psöriazis hastalarında kontrollere göre daha yüksek olması ve PAŞİ skoru ile ilişkili olması inflamasyon belirteci olarak kullanılmasının TLO ve NLO’ ya kıyasla daha yararlı bir belirteç olduğunu göstermektedir

🔖

Cite This Article

AN, İ., UÇMAK, D. (2018). Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in patients with psoriasis vulgaris. Dicle Tıp Dergisi, Cilt: 45 - Sayı: 3, 327–334. https://ajindex.com/articles/192534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literatüre. JEADV. 2014; 28: 700-11.
  2. Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010; 24: 789–96
  3. Saleh HMA, Attia EAS, Onsy AM, Saad AA, Abd Ellah MMM. Platelet activation: a link between psoriasis per se and subclinical atherosclerosis - a case - control study. Br J Dermatol. 2013; 169: 68-75 Sahpaz P,Ulutas KT. Assessment of mean platelet volume in type 2 diabetics receiving insulin or oral antidiabetic agents. Dicle Med J. 2015; 42: 399-403.
  4. Incebıyık A, Uyanıkoglu H. Is there a role mean platelet volume in the diagnosis of patients with adnexal torsion? Dicle Med J. 2017; 44: 333-7.
  5. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010; 8: 148-56.
  6. Yurtdas M, Yaylali YT, Kaya Y et al. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography. 2014; 31: 1095–104.
  7. Cerman AA, Karabay EA, Altunay IK. Evaluation of neutrophil-lymphocyte ratio and mean platelet volume in patients with psoriasis. SETB. 2016; 50: 137-41
  8. Ataseven A, Bilgin AU, Kurtipek GS. The importance of neutrophil lymphocyte ratio in patients with psoriasis. Clin Med Res. 2014; 3: 40–3.
  9. Yurtdaş M, Yaylali YT, Kaya Y, et al. Neutrophilto Lymphocyte Ratio May Predict Subclinical Atherosclerosis in Patients with Psoriasis. Echocardiography. 2014; 31: 1095-104.
  10. Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016; 43: 305-10. Sengül E,Ozbay M, Topcu I. Relationship between Neutrophil-to-Lymphocyte Ratio and Prognosis in Patients with Deep Neck Space Infection. Dicle Med J. 2016; 43: 126-9.
  11. Gunabatar H, Ekin S, Sunnetcioglu H, et al. The relationship between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with obstructive sleep apnea syndrome. Dicle Med J. 2015; 42: 289-93.
  12. Cemil BC, Atas H. The Effect of Biological Treatment onto Systemic Inflammatory Markers and Plateletcrit in Psoriasis Patients. Dicle Med J. 2016; 43: 477-83.
  13. Balta S, Cakar M, Demirkol S, Arslan Z, Akhan M. Higher neutrophil to lymphocyte ratio in patients with metabolic syndrome. Clin Appl Thro